In the recent study by Bosco and colleagues, luminal tumour-derived cell lines were shown to be more proliferative and resistant to hormone therapy after knockdown of RB1 [32], both of which are signatures of luminal B tumours [9-11]. This evidence concerns the gene RB1 and neoplasm.